The House Energy and Commerce Committee will hold hearings next week to discuss how mobile health applications should be regulated by the FDA. Earlier this month, panel members sent a letter to the FDA citing concerns that developers could be subject to a tax under the Affordable Care Act if the agency classifies such apps as medical devices.

Related Summaries